Shionogi Investor
Shionogi provides pharmaceuticals, diagnostic reagents, and medical devices. They specialize in generic drug manufacturing. They engage in manufacturing, formulation, packaging, and analysis of commercialization research that spans late-stage drug discovery through commercial production.
Investor Type:
Private Equity Funds
Technology:
Clinical Decision Support Systems (CDSS)
Founded Date:
1878-03-17
Industry:
Clinical AI
Funding Status:
public
Headquarters:
Osaka-shi,Osaka,Japan,Asia